David T. Drummond ⎜Nov 15, 2016 ⎜ Supplier
Fast implementation of positron emission tomography (PET) into clinical and preclinical studies highly demands automated synthesis for the preparation of PET radiopharmaceuticals in a safe and reproducible manner. The aim of this study was to develop automated synthesis methods for these six 18F-labeled radiopharmaceuticals produced on a routine basis at the University of Pennsylvania using (more…)
David T. Drummond ⎜Oct 12, 2016 ⎜ Market
“Applications for molecular imaging technologies continue to increase and our industry continues to expand.” – David Drummond, Managing Director and Founder of isoSolutions
PET market poised for healthy growth By www.auntminnie.com link
October 11, 2016 — Driven by an increasing prevalence of chronic disorders and greater market penetration of PET systems, the global PET scanner sector will grow at a compound annual growth rate (CAGR) of 4.7% between 2016 and 2026, according to a new report by market research firm Future Market Insights. (more…)
David T. Drummond ⎜Sep 24, 2016 ⎜ Supplier
ln produced on a routine basis at UPENN with the Trasis AllinOne synthesizer.
By Ramona Delcea, Trasis Download pdf
David T. Drummond ⎜Sep 15, 2016 ⎜ Market
“This is a period of profound change for the Mo-99 supply network that is key to our industry.” – David Drummond, Managing Director and Founder of isoSolutions.
September 13, 2016 — Supplies of a key radioisotope used in nuclear cardiology scans could be disrupted next month when a Canadian nuclear reactor begins shutting down. U.S. healthcare providers could be left scrambling for new sources of molybdenum-99 (Mo-99) until other suppliers are able to step in and fill the void. (more…)